Connolly, Stuart J; Camm, A John; Halperin, Jonathan L; Joyner, Campbell; Alings, Marco; Amerena, John; Atar, Dan; Avezum, Álvaro; Blomström, Per; Borggrefe, Martin; Budaj, Andrzej; Chen, Shih-Ann; Ching, Chi Keong; Commerford, Patrick; Dans, Antonio; Davy, Jean-Marc; Delacrétaz, Etienne; Di Pasquale, Giuseppe; Diaz, Rafael; Dorian, Paul; ... (2011). Dronedarone in high-risk permanent atrial fibrillation. New England journal of medicine NEJM, 365(24), pp. 2268-76. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1109867
|
Text
nejmoa1109867.pdf - Published Version Available under License Publisher holds Copyright. Download (614kB) | Preview |
Dronedarone restores sinus rhythm and reduces hospitalization or death in intermittent atrial fibrillation. It also lowers heart rate and blood pressure and has antiadrenergic and potential ventricular antiarrhythmic effects. We hypothesized that dronedarone would reduce major vascular events in high-risk permanent atrial fibrillation.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology |
UniBE Contributor: |
Delacrétaz, Etienne |
ISSN: |
0028-4793 |
Publisher: |
Massachusetts Medical Society MMS |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:22 |
Last Modified: |
05 Dec 2022 14:06 |
Publisher DOI: |
10.1056/NEJMoa1109867 |
PubMed ID: |
22082198 |
Web of Science ID: |
000298031800007 |
BORIS DOI: |
10.7892/boris.7372 |
URI: |
https://boris.unibe.ch/id/eprint/7372 (FactScience: 212591) |
Actions (login required)
 |
Edit item |